ADVOCACY
-
Important survey about hemophilia B gene therapy – THE CLOCK IS TICKING!
The 1st gene therapy for hemophilia B (factor IX deficiency) is currently undergoing an evaluation by Canadian health authorities. This review will determine whether or...
-
Update on the 1986-1990 Hepatitis C Compensation Program
As the result of the latest actuarial study to the end of the year 2019, the Joint Committee announced in early 2021 that the Fund...
-
Climbing Mount Kilimanjaro for a good cause
On Friday, June 30, Maia Meier and Craig Upshaw, longstanding CHS volunteers, will start their climb to the top of Mount Kilimanjaro. Both Maia and...
-
The Serbia-Manitoba Chapter twinning partnership receives the WFH 2022 Twins of the Year award!
It was with great pride that the CHS learned that the World Federation of Hemophilia (WFH) had granted the 2022 Hemophilia Organization Twins of the...
-
2022 CHS Annual Report
Please CLICK HERE to access the 2022 CHS Annual Report. Should you want to consult the complete Financial Statements, you can do so by clicking HERE.